AMP Health is overseen by our Partnership Board, which is comprised of leaders from both the public and private sectors with tremendous expertise and insight. Learn more about our current partners.
Chair: Wendy Taylor - Fellow, The Rockefeller Foundation
Wendy Taylor has worked for the last 20 years catalyzing innovations to tackle some of the world’s toughest global health challenges and utilizing market-based solutions to scale for impact. In 2017, she was awarded a Rockefeller Foundation Fellowship to explore how to advance opportunities in artificial intelligence, digital health and data technologies to transform global health, including applying advanced outbreak analytics to pandemic threats enabling effective outbreak prediction, earlier detection and precision response.
Joining the Obama Administration in 2010 as a presidential appointee, Wendy founded and built the Center for Accelerating Innovation and Impact at the US Agency for International Development (USAID) to apply innovative, business-minded approaches to accelerate the development, introduction and scale-up of priority global health innovations. As Director of the Center, she spearheaded multiple Grand Challenges to globally crowdsource groundbreaking solutions to tough health problems – from maternal and newborn health to Ebola to Zika and Future Threats – investing $140 million in new innovations. She also created the agency’s first advance purchase commitments to stimulate investments in vaccines and diagnostics and created multiple public private partnerships with corporations from GSK and McCann Health to Coca-Cola to expand and strengthen health markets.
In 2004, she founded Bio Ventures for Global Health (BVGH), a non-profit working to engage the biopharmaceutical industry in developing medicines for diseases of the developing world. At BVGH, Wendy accelerated global health research and development by building partnerships, identifying market opportunities for industry engagement and advancing the development or implementation of new market incentives including the first Advance Market Commitment and FDA’s Priority Review Voucher program. She also held senior positions with the Biotechnology Industry Organization (BIO) – where she negotiated the third reauthorization of the Prescription Drug User Fee Act (PDUFA) on behalf of the biotech industry and developed the organization’s first global health program – and Malaria No More, and she worked in both the executive and legislative branches of the US government, including the Office of Management and Budget and the U.S. House Committee on Ways and Means.
Wendy currently serves on the boards of Last Mile Health, D-Rev and Bio Ventures for Global Health and on several advisory boards, including UNICEF’s Products and Markets Advisory Board and the Sabin-Aspen Vaccine Science and Policy Group. She received a Master of Public Policy from Harvard University and a B.A. from Duke University.
Agnes Binagwaho - Vice Chancellor, University of Global Health Equity, Rwanda
Professor Agnes Binagwaho is a Rwandan pediatrician who completed her MD in General Medicine at the Universite Libre de Bruxelles and her MA in Pediatrics MA at the Universite de Bretagne Occidentale. She returned to Rwanda in 1996. She was awarded an Honorary Doctor of Science from Dartmouth College and earned a Doctorate of Philosophy from the University of Rwanda College of Business and Economics, with her PhD Dissertation titled, “Children’s Right to Health in the Context of the HIV Epidemic.”
From 2002-2016, she served in the Rwandan Health Sector in high-level government positions, first as the Executive Secretary of Rwanda’s National AIDS Control Commission, then as Permanent Secretary of the Ministry of Health, and then during 5 years as the Minister of Health. She is currently a Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School, a Professor of the Practice of Global Health Delivery at University of Global Health Equity, and an Adjunct Clinical Professor of Pediatrics at the Geisel School of Medicine at Dartmouth.
Adrien de Chaisemartin - Director of Strategy, Funding, and Performance, Gavi
Adrien de Chaisemartin is the Director of Strategy, Funding, and Performance at Gavi, the Vaccine Alliance. He leads the processes related to Gavi strategy as well as the review, approval and monitoring of the grants provided to countries and partners ($2B per year). Adrien played a lead role in defining the Gavi 2016-2020 strategy and in redefining the engagement model with countries and Alliance partner organizations. This new model entailed a major emphasis on coverage and equity of immunisation programmes, as well as the development of various approaches to support better leadership and management of these programs in the 73 countries supported by Gavi.
Prior to joining Gavi in 2011, Adrien worked at McKinsey & Company in Johannesburg, South Africa. For 6 years Adrien supported governments, foundations and UN institutions in Kenya, Tanzania, Ethiopia, Botswana and South Africa on programs in the areas of public health and economic development. As part of the Non-Profit Practice of McKinsey, he also led various research projects on effectiveness of development aid and on climate-resilient development.
Adrien is a French national. He holds a Master of Science from Ecole Polytechnique, and a Master of Science in Applied Mathematics from Harvard University.
Peggy Clark - Executive Director, Aspen Global Innovators Group
Peggy Clark is Vice President of Policy Programs and Executive Director of Aspen Global Innovators Group. Peggy has had a 30-year career working on issues of poverty alleviation, global health, social enterprise, and development finance. Serving in founding and leadership roles at the Aspen Institute, the Ford Foundation, Save the Children, Realizing Rights, and on boards including Root Capital, Last Mile Health, Impact Assets, the African Leaders Malaria Alliance and the Calvert Foundation, Peggy has been a leading figure in identifying and building industries, movements, and creative advocacy on key issues of our times. Peggy received a Presidential Award for Excellence in Microenterprise from President Bill Clinton, and was instrumental in passage of the WHO Global Code of Practice on the Ethical Recruitment of Health Workers. Currently, Peggy directs a portfolio of programs promoting breakthrough solutions to global development in the areas of health innovation, leadership and entrepreneurship. Previously, Peggy served as the Executive Vice President of the Aspen Institute, co-founder and Managing Director of Realizing Rights, Chair of the Women’s Program Forum at the Ford Foundation, and as the first Director of Small Scale Enterprise and Credit at Save the Children Federation.
Scott Higgins - Director of Operations, Merck for Mothers
Scott Higgins is an accomplished business executive with over 25 years of experience guiding organizations through transformational change. As Director of Operations for Merck for Mothers, he leads efforts to implement global programs that help reduce maternal mortality. His responsibilities include project management, reporting, budget tracking, and ensuring compliance with grant requirements.
Scott has a broad background in the pharmaceutical industry. He has served in leadership roles in Active Pharmaceutical Ingredient (API) chemical manufacturing, environmental control operations, strategic sourcing, and process improvement. Prior to joining Merck for Mothers, Scott led the Global Supplier Management Group's Process Operations and Strategy organization.
Scott holds a BS in Chemical Engineering from Bucknell University. He is a Lean Six Sigma Master Black Belt and certified Change Agent.
Shira Kilcoyne - Director, Government Affairs, Emerging Markets & Asia Pacific, GSK
As Director of Government Affairs, Emerging Markets & Asia Pacific, Shira Kilcoyne is responsible for designing and leading integrated public and government affairs programs to support GlaxoSmithKline operations in 118 countries outside the US and Europe. Her primary role is to develop partnerships that help achieve GSK’s commitment to improve access to medicines, work with Governments to find innovative solutions to provide the best treatments possible for patients, encourage fair, transparent and pro-innovation regimes, and improve and/or accelerate market access opportunities for GSK products.
Shira joined GlaxoSmithKline in 2004 as Manager, Government Affairs, International. Prior to joining GlaxoSmithKline, Shira served as Manager Asia Pacific Affairs for the Pharmaceutical Research Manufacturers of America, PhRMA. In her role at PhRMA, she worked with senior executives from the research based pharmaceutical industry to create and defend policy that recognizes and awards innovative medicines.
Prior to joining PhRMA, Shira was the lead event coordinator for Investor Broadcast Network. In this capacity, she worked with investor relations departments of Fortune 500 companies to ensure they were meeting their Securities Exchange Commission obligations.
Shira earned her Bachelor of Arts in Business and Spanish at the University of Maryland in 1998 and earned her Masters of Business Administration at the University of Maryland in 2005. She lives in Maryland with her husband, two daughters and son.
David Milestone - Acting Director, Center for Accelerating Innovation and Impact, USAID
David Milestone is Acting Director of USAID's Center for Accelerating Innovation and Impact (CII). CII applies business-minded approaches to the development, introduction and scale-up of health innovations. To do so, CII invests seed capital in the most promising ideas and applies a rigorous, market-oriented approach to cut the time it takes to transform discoveries in the lab to impact on the ground.
Most recently, David held various strategic marketing roles at Stryker, a $11B medical device company, where he led innovation, introduction, and strategy initiatives in India. He has also worked as a management consultant with AT Kearney providing guidance to Fortune 500 companies on strategy and operations.
He holds an MBA from the Kellogg School of Management at Northwestern University, an MPA from Harvard’s Kennedy School of Government, an MS in Mechanical Engineering from Stanford University, and a BS in Mechanical Engineering from the University of Wisconsin-Madison.
Joy Phumaphi - Executive Secretary, African Leaders Malaria Alliance
The Honorable Joy Phumaphi is the Executive Secretary of the African Leaders Malaria Alliance. She is the former Minister of Health of Botswana. Prior to serving as the Minister of Health, she began public service in Botswana as a local government auditor and went on to serve in Parliament and as a representative to the Southern African Development Community. In 2003, Ms. Phumaphi joined the World Health Organization as the Assistant Director General for Family and Community Health Department. She has previously served as Vice President and Head of the Human Development Network at the World Bank and Commissioner in the UN Secretary-General’s Commission on HIV/AIDS and Governance in Africa. She is also a member of the Women's Leadership Initiative for Microbicides and the Bill & Melinda Gates Foundation Advisory Panel for Global Health. She is a board member of The Global Health Council, Save the Children International, the Africa American Institute, and a trustee of the Children’s Investment Fund Foundation.
English Sall - Board Member, Sall Family Foundation
English Sall is a data enthusiast and researcher at heart. She is a board member of the Sall Family Foundation and is pursuing the role of a next gen philanthropist. English is currently pursuing her PhD in Industrial Organizational Psychology (IOP) at North Carolina State University. English specializes in Humanitarian Work Psychology and is especially interested in how IOP can be applied to cross-cultural leadership and work-force development within informal economies.
She is co-founder of an organization called Impact Thread. Using industrial organizational psychology Impact Thread addresses workforce and organizational development through the lens of social good. Throughout her undergraduate and graduate career, English has gained diverse experience designing research projects and utilizing applied analytics in the space of Humanitarian Work Psychology.
English is a recipient of The Dedication Medal from the Red Cross for dedication to providing Life Saving Blood Services and has received recognition for her work with the Cystic Fibrosis Foundation.
English is also a board member of Jacaranda Health, EducationNC, and the Jamie Kirk-Hahn Foundation. English has worked as a Data Strategist Fellow with Organize and as a member of the Society for Industrial and Organizational Psychologists-United Nations Liaison team. English was also co-director for Aspen Institute’s Impact Careers Initiative and is currently a member of the Maverick Collective.
Jenny Sia - Director, Corporate Responsibility, Pfizer
Jenny Sia is Director, Corporate Responsibility and leads global health grant making and impact investing for Pfizer Inc and the Pfizer Foundation, key elements of Pfizer’s strategy to improve access to medicines and healthcare. Through this she is responsible for the Pfizer Foundation’s impact investing strategy to support health delivery and social innovation, as well as programs to advance Women and Children’s Health and Non-Communicable Disease Care in Africa, Asia and Latin America.
Jenny has been a member of Pfizer’s corporate responsibility team since 2003 and has worked in several areas including public reporting, stakeholder engagement and investor outreach, and policy development. She spent a year in Beijing developing a Corporate Responsibility strategy for Pfizer China.
Jenny received a Masters in Public Policy with a specialization in international economic policy at Columbia’s School of International and Public Affairs. She earned a BS from Tulane University.
Chuck Slaughter - Founder and President, Living Goods
Chuck earned a BA in Architecture and a Master’s in Public and Private Management from Yale. After trying and failing to build successful businesses in bike repair and then documentary film, Chuck founded TravelSmith, and grew it into a leading travel gear company with over $100 million in catalog and online sales. In affiliation with private equity firm Golden Gate Capital, he participated in the acquisition and turnaround of several major apparel brands with combined sales over $2 billion.
Seeking to apply his business skills to a more meaningful purpose Chuck lead the turnaround of a system of franchised clinics serving the poor in Kenya. This experience inspired Chuck to create Living Goods, which operates networks of ‘Avon-like’ health entrepreneurs who go door-to-door teaching families how to improve their health and wealth and selling life-changing products, like treatments for malaria and diarrhea, fortified foods, family planning, clean cook stoves, and solar lights. Living Goods empowers agents with an innovative smart phone app that automates diagnosis, ensures prompt follow ups and provides real time data to every manager on any device. A recent randomized evaluation shows the Living Goods model is reducing child mortality by over 25%, for less than $2 per capita. Working closely with local governments Living Goods is helping solve two of the most vexing problems in community health: how to keep vital medicines in stock, and how to pay the millions of health workers needed. Now LG’s advisory division is helping some the worlds largest NGOs replicate the model in Uganda, Kenya, Myanmar and Zambia.
Chuck serves on the boards of Yale’s School of Management and the Horace Goldsmith Foundation. He received an Ernst and Young Entrepreneur of the Year Award, a Draper Richards Fellowship, and is a World Economic Forum Social Entrepreneur of the Year.
Jeff Walker - Vice-Chair, Community Health Workers, MDG Health Alliance
Active board member, consultant and advisor to non-profit institutions and social enterprises, Jeff Walker currently serves on the Boards of New Profit, Berklee College of Music, Morgan Library, Lincoln Center Film Society, Millennium Development Goals Health Alliance, the Miller Center and University of Virginia’s Undergraduate Business School, where he was President for ten years. He is also a Co-founder and Co-chairman of Quincy Jones Musiq Consortium, Chairman of the Council of Foundations at University of Virginia, serves on the Visiting Committee at the Harvard Business School and is on the Advisory Boards of the MIT Media Lab, the Blue School, the Tibetan Village Project and Ideo.org. He is also President of 15 Central Park West.
Previously, Jeff was Executive-in-Residence at Harvard Business School, focusing on Social Enterprises and Collaboration and a lecturer at the Kennedy School. At Harvard, he also helped to develop and launch “A Course in Exponential Fundraising” for nonprofit leaders at the Hauser Center for Nonprofit Organizations. He served as the Chairman of Millennium Promise, an incubator to eliminate extreme poverty with the United Nations and Columbia University and was the long-time Chairman of the Thomas Jefferson Foundation (Monticello), where he still serves as an emeritus trustee. He also Co-founded and was Chairman of Npower, an organization that provides shared technology services to nonprofits.
Jeff was Chairman and CEO of CCMP Capital, the $12 billion successor to JPMorgan Partners, JPMorgan Chase & Co’s global private equity and Chairman of the JPMorgan Chase Foundation. A Certified Public Accountant and a Certified Management Accountant, Jeff graduated with a B.S. from the University of Virginia and an M.B.A. from Harvard Business School.
Kara Weiss - Program Director, Child Relief International Foundation
Kara Weiss is the Program Director at Child Relief International Foundation. Kara is involved in all aspects of vetting and managing grantees with a special interest in earliest stage NGO partnership, as well as strategy. Kara is the CRI lead on system-change initiatives, including nations-wide digital health cooperation and implementation, and the Health and Nutrition Risk Pool Fund pilot to prove the efficacy of providing contingency funding forimplementers. Over the years, CRI has developed many relationships with those participating in social entrepreneurship in sub-Saharan Africa and Kara is especially adept at facilitating synergistic relationships among actors and funders.
Kara is an Ambassador for the African Alliance of Digital Health Networks, and serves on the boards of Gardens for Health International, Spark MicroGrants, and the Center for Development Economics. Kara holds degrees from Williams College and the University of Washington.